Sponsorluk
Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26
Posted
India's pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry's optimistic outlook.
Site içinde arama yapın
Kategoriler
- National
- International
- Business
- Technology
- Health
- EĞİTİM BİLGİLERİ
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Most banks see muted loan growth in June quarter
India's banking sector experienced a slowdown in the June quarter, marked by subdued credit...
Why Jane St ban may not hit trading
Following Sebi's order against Jane Street, market players anticipate improved compliance among...
How much would you pay for 10-min delivery?
Quick commerce platforms like Swiggy Instamart and Blinkit are facing consumer pushback due to...
PSBs may remove min balance fines
Following finance ministry concerns over declining low-cost deposits, several public sector...